ESG

As AI's power thirst grows, the engineering giant realigns to deliver integrated energy, water, and data solutions for a new era of critical infrastructure.

With over AUD$1M in sales from its first MDMA batch, Cortexa is validating Australia's pioneering move to legalize psychedelic-assisted therapy.

EPRI's new Flex MOSAIC framework promises to slash grid connection times for data centers, a critical step to unlocking the growth of the AI revolution.

Clarius launches T-Mode, an AI-powered training tool that demystifies heart and knee ultrasounds for frontline clinicians, promising faster diagnosis.

New All-in-One unit promises faster charging, smaller footprints, and lower costs, accelerating the high-power EV charging race in North America.

Niche's 2026 rankings reveal a major shift: Americans are choosing smaller, walkable communities that blend urban access with neighborhood charm.

A new collaboration aims to solve antibody reproducibility, promising to enhance diagnostic accuracy and accelerate the future of precision oncology.

New research reveals a startling link between common liver conditions and heart failure in older adults with atrial fibrillation, urging a new look at risk.

A new partnership will use predictive simulation to design ultra-durable alloys for The Exploration Company's Nyx, accelerating the future of space logistics.

Sydnexis's eye drop trial shows high efficacy in children 3-12, positioning it as a potential first-of-its-kind FDA-approved drug for myopia.

A new $16B Texas power plant, part of a U.S.-Japan deal, aims to fuel the data center boom without raising consumer bills. Can this massive project succeed?

A landmark land lease agreement paves the way for Taiwan's first onshore wave energy station, a key test for the island's renewable goals and a major win for Eco Wave Power.

Lifecore Biomedical secures its third major manufacturing deal in five months, signaling a strategic shift that could reshape the aesthetics supply chain.

With key trial enrollment complete, Pyxis Oncology refines its cancer drug MICVO for safety and prepares for pivotal data under a new, seasoned CEO.

With a new grant, Tessera Therapeutics is advancing its novel Gene Writing platform to engineer a scalable, single-shot cure for HIV. But can it work?

Genomics leader IDT launches its first IVD-grade NGS tests for cancer, aiming to standardize diagnostics and accelerate precision medicine.

Facing financial headwinds, Cyber Enviro-Tech signs a major deal to bring compressed air power to emerging markets. But can the technology and the company deliver?

A new one-hour test for sepsis could change critical care, offering rapid results that help doctors fight the clock and save lives. Here's how it works.

With major expansions in the US and Europe, Cambrex aims to lead the high-stakes race for specialized API production, targeting next-generation therapies.

Diageo's YunTuo distillery sweeps top honors, proving that Chinese-origin single malt is ready for the world stage. A new chapter in whisky begins.